Epstein-Barr virus infections in pregnancy: a prospective study

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Virology

Background:

• Epstein-Barr virus (EBV) is a common human herpesvirus.
• Primary EBV infection during pregnancy may pose risks to fetal development.
• Understanding EBV transmission during gestation is crucial for prenatal care.

Purpose of the Study:

• To investigate the incidence of Epstein-Barr virus (EBV) seroconversion in pregnant women.
• To determine if intrauterine EBV infection occurs and assess potential fetal outcomes.

Main Methods:

• Prospective study of 4063 pregnant women across 4108 gestations.
• Serological testing for EBV susceptibility and seroconversion early in gestation.
• Neonatal assessment for EBV-specific IgM antibodies and lymphocyte analysis.

Main Results:

• Only 1.1% (46/4063) of women were susceptible to EBV early in gestation.
• Three women showed seroconversion during pregnancy.
• Infants born to seroconverting mothers did not exhibit signs of intrauterine EBV infection.

Conclusions:

• The study did not document any cases of intrauterine Epstein-Barr virus infection.
• Evidence suggests a low risk of EBV transmission to the fetus during gestation in this cohort.
• Further research may be needed to fully elucidate the impact of maternal EBV infection on pregnancy outcomes.